Resources in English

Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis

Boregowda, Umesha et al. (2020-10-02)

Introduction: Tocilizumab (TCZ) is an anti-interleukin-6 antibody that has been used for the treatment of severe coronavirus disease 2019 (COVID-19). However, concrete evidence of its benefit in reducing mortality in severe ...

Mental health outcomes of adults hospitalized for COVID-19: A living rapid review

O'Neil, M. et al. (2020-10-01)

Scope: This rapid review compares the prevalence of mental health disorders among adults who have been hospitalized for COVID-19 to relevant comparison groups, assesses whether the prevalence of mental health disorders ...

The Prognostic Value of Thrombocytopenia in COVID-19 Patients; a Systematic Review and Meta-Analysis

Bashash, Davood et al. (2020-09-22)

Introduction: Multiple lines of evidence have attested that decreased numbers of platelets may serve as a surrogate marker for poor prognosis in a wide range of infectious diseases. Thus, to provide a well-conceptualized ...

COVID-19 pandemic and maternal mental health: a systematic review and meta-analysis

Hessami, Kamran et al. (2020-11-01)

Objective: To evaluate the effect of the COVID-19 pandemic on anxiety and depression of women during pregnancy and perinatal period. Methods: We systematically searched online databases to identify any report on maternal ...

Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis

Zhang, Hua et al. (2020-11-02)

Background: Previous studies have indicated coronavirus disease 2019 (COVID-19) patients with cancer have a high fatality rate. Methods: We conducted a systematic review of studies that reported fatalities in COVID-19 ...

Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data

Park, Robin et al. (2020-11-02)

Background: Cancer patients suffer from worse coronavirus disease-2019 (COVID-19) outcomes. Whether active oncologic treatment is an additional risk factor in this population remains unclear. Therefore, here we have conducted ...

Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients

Cheruiyot, Isaac et al. (2020-11-03)

Background: Emerging evidence suggests that a subset of coronavirus disease 2019 (COVID-19) patients may present with or develop cerebrovascular disease during the course of hospitalization. Whereas ischemic stroke in ...

Neurological Involvement in COVID-19 Patients: A Narrative Review

Yadav, Ramakant et al. (2020-09-04)

Background: Coronavirus disease 2019 (COVID-19) is a viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belonging to the coronavirus family. The primary target of SARS-CoV-2 is peripheral ...

Venous Thromboembolism in Hospitalized COVID-19 Patients

Sridharan, Gurusaravanan Kutti et al. (2020-11-30)

Background: Venous thromboembolism (VTE) is increasingly reported in seriously ill patients with COVID-19 infection. Incidence of VTE has been reported before and results varied widely in study cohorts. Area of uncertainty: ...

The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis

Matsushita, Kunihiro et al. (2020-09-22)

Background: Whether cardiovascular disease (CVD) and its traditional risk factors predict severe coronavirus disease 2019 (COVID-19) is uncertain, in part, because of potential confounding by age and sex. Methods: We ...

The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review

Kiss, Pauline et al. (2020-11-05)

Background: The COVID-19 pandemic has disrupted healthcare services around the world, which may have serious implications for the prognosis of patients with acute cardiovascular disease. We conducted a systematic review ...

Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis

Ssentongo, Anna E. et al. (2020-11-05)

Objective: The association between the use of renin–angiotensin–aldosterone (RAAS) inhibitors and the risk of mortality from COVID-19 is unclear. We aimed to estimate the association of RAAS inhibitors, including ACE ...

Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: A systematic review of a globally representative sample

Hasan, Irtiza et al. (2020-11-05)

Introduction: COVID-19 presents a special challenge to the kidney transplant population. Methods: A systematic review of articles that examined COVID-19 in kidney transplant recipients was performed. Patients' demographics, ...

Mental health services for infectious disease outbreaks including COVID-19: a rapid systematic review

Yue, Jing-Li et al. (2020-11-05)

The upsurge in the number of people affected by the COVID-19 is likely to lead to increased rates of emotional trauma and mental illnesses. This article systematically reviewed the available data on the benefits of ...

The Cardiac Toxicity of Chloroquine or Hydroxychloroquine in COVID-19 Patients: A Systematic Review and Meta-regression Analysis

Tleyjeh, Imad M. et al. (2020-10-19)

Objective: To systematically review the literature and estimate the risk of Chloroquine (CQ) and hydroxychloroquine (HCQ) cardiac toxicity in COVID-19 patients. Methods: We searched multiple data sources including ...